X0306 4 2012-05-14 0 0000887151 Capstone Therapeutics Corp. CAPS 0000949119 MILLER LLOYD I III 222 LAKEVIEW AVENUE SUITE 160-365 WEST PALM BEACH FL 33401 0 0 1 0 Common Stock 2012-07-05 4 P 0 1114 0.16 A 303067 I By Milfam II L.P. Common Stock 2012-07-06 4 P 0 8750 0.16 A 311817 I By Milfam II L.P. Common Stock 2012-07-11 4 P 0 63000 0.1773 A 374817 I By Milfam II L.P. Common Stock 2012-07-13 4 P 0 17000 0.18 A 391817 I By Milfam II L.P. Common Stock 2012-07-16 4 P 0 23058 0.18 A 414875 I By Milfam II L.P. Common Stock 2012-07-18 4 P 0 22000 0.175 A 436875 I By Milfam II L.P. Common Stock 2012-07-23 4 P 0 35917 0.1709 A 472792 I By Milfam II L.P. Common Stock 2012-09-14 4 P 0 27225 0.135 A 27225 I By Trust D - Lloyd I. Miller Common Stock 2012-09-17 4 P 0 30102 0.135 A 57327 I By Trust D - Lloyd I. Miller Common Stock 2012-09-19 4 P 0 33017 0.135 A 90344 I By Trust D - Lloyd I. Miller Common Stock 641218 I By Milgrat Q8 Common Stock 724100 I By Milfam NG LLC Common Stock 58967 D The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. This filing shall not be deemed an admission that the reporting person is, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the beneficial owner of any equity securities covered by this filing. The price in Column 4 is a weighted average price. The price actually paid ranged from $0.161 to $0.171 per share. The reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range. It is necessary to file this Form 4 in three parts in order to incorporate all line entries. This constitutes the third of three Form 4's to be filed as of the date hereof. /s/ David J. Hoyt Attorney-in-fact 2012-11-29